Cite
Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients.
MLA
Leyfman, Yan, et al. “Cancer and COVID-19: Unravelling the Immunological Interplay with a Review of Promising Therapies against Severe SARS-CoV-2 for Cancer Patients.” Journal of Hematology & Oncology, vol. 16, no. 1, Apr. 2023, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s13045-023-01432-6.
APA
Leyfman, Y., Emmanuel, N., Menon, G. P., Joshi, M., Wilkerson, W. B., Cappelli, J., Erick, T. K., Park, C. H., & Sharma, P. (2023). Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients. Journal of Hematology & Oncology, 16(1), 1–15. https://doi.org/10.1186/s13045-023-01432-6
Chicago
Leyfman, Yan, Nancy Emmanuel, Gayathri P. Menon, Muskan Joshi, William B. Wilkerson, Jared Cappelli, Timothy K. Erick, Chandler H. Park, and Pushpa Sharma. 2023. “Cancer and COVID-19: Unravelling the Immunological Interplay with a Review of Promising Therapies against Severe SARS-CoV-2 for Cancer Patients.” Journal of Hematology & Oncology 16 (1): 1–15. doi:10.1186/s13045-023-01432-6.